BioCentury
ARTICLE | Clinical News

NCX 1022: Phase I data

October 8, 2007 7:00 AM UTC

NicOx S.A. (Euronext:COX), Sophia-Antipolis, France Ferrer Internacional S.A., Barcelona, Spain Product: NCX 1022 Business: Dermatology Molecular target: Cyclooxygenases (COX) Description: Nitric ox...